Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.
NCT00043446 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2005-06-24
Summary
The purpose of this study is to determine whether T900607-sodium is effective and safe in treating ovarian cancer.
Conditions
- Ovarian Neoplasms
Interventions
- DRUG
-
intravenous T900607-sodium
Sponsors & Collaborators
-
Tularik
lead INDUSTRY
Principal Investigators
-
Kerrie Boyd · Tularik
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
Countries
- United States
Study Locations
More Related Trials
-
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.
NCT00408967 ·Status: WITHDRAWN ·Phase: PHASE2
-
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00022347 ·Status: COMPLETED ·Phase: PHASE2
-
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
NCT00102622 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779 ·Status: RECRUITING ·Phase: PHASE3
-
Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
NCT00093626 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
NCT00038428 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00006391 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer
NCT00246688 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
NCT06824467 ·Status: RECRUITING ·Phase: PHASE3
-
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
NCT00051948 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT03586661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00019461 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3
-
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
NCT00003644 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
NCT04406623 ·Status: COMPLETED ·Phase: PHASE1
-
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
NCT00010179 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer
NCT03029585 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Isoquercetin in People With Ovarian Cancer
NCT07303894 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer
NCT02303912 ·Status: COMPLETED ·Phase: PHASE1
-
Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00079430 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
NCT00050414 ·Status: COMPLETED ·Phase: PHASE2
-
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer
NCT00170664 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Niraparib in Patients With Relapsed Ovarian Cancer
NCT04392102 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777 ·Status: COMPLETED ·Phase: PHASE1
-
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
NCT02399592 ·Status: COMPLETED ·Phase: PHASE2